The building materials distributor sees its return on capital employed fall to 2.3%, significantly trailing the industry average, raising questions about its reinvestment strategy and growth trajectory.
Pzena Investment Management's Focused Value Strategy underperformed in Q4 2025, citing a challenging environment dominated by mega-cap AI stocks. Healthcare giant Baxter International was singled out as a significant drag on the portfolio's performance during the period.
Amid a quarter dominated by mega-cap tech and AI fervor, Pzena Investment Management's Focused Value Strategy found pockets of opportunity. While trailing its benchmark, the fund highlighted Citigroup as a standout performer, pointing to a potential rotation as valuation gaps widen.
Despite a recent earnings miss that left shares flat, a deeper look at Knight-Swift Transportation's finances reveals a stronger underlying business, with significant one-off costs masking operational resilience.
PayPal Holdings Inc. reported fourth-quarter revenue that fell short of Wall Street expectations, sending its stock plunging nearly 15% and raising questions about the digital payments pioneer's growth trajectory in a competitive market.
Despite underperforming the market over the past year, analysts maintain a 'Moderate Buy' stance on Healthpeak Properties, with price targets suggesting significant upside as the healthcare REIT executes its portfolio transformation and plans a senior housing spin-off.
Barclays plans to close Tesco Bank's Newcastle office, relocating most roles to Glasgow and putting 162 positions under consultation, in a move unions vow to scrutinize.
In a parliamentary submission, the crypto exchange alleges major Australian banks are unlawfully cutting off services to legitimate digital asset firms, creating a 'crisis of confidence' and stifling innovation as the country moves to formalize crypto regulation.
India's Supreme Court has issued a stern warning to Meta's WhatsApp, questioning its data monetization and user consent model in a market where the app holds a dominant position. The court has temporarily barred data sharing pending a detailed examination.
As the TSX rides a wave of robust Q4 earnings, savvy investors are looking past the blue chips. We delve into three lesser-known Canadian companies—spanning energy, aerospace, and energy services—that combine solid fundamentals with strategic moves to capitalize on current economic tailwinds.
BellRing Brands (NYSE: BRBR) reported fourth-quarter revenue that surpassed analyst expectations, though sales remained flat year-over-year. The company's full-year outlook and adjusted earnings also topped consensus forecasts, painting a picture of resilient performance amid a challenging market for consumer staples.
Pharmaceutical giant Merck & Co. reported fourth-quarter revenue that surpassed Wall Street forecasts, driven by robust demand for its key products. However, a more conservative full-year sales projection and a sharp expected decline in earnings for the coming year tempered the positive results, sending shares lower in after-hours trading.
Despite a strong 52-week performance and a key new partnership with Worldpay, Regions Financial's stock is met with a tepid 'Hold' consensus from Wall Street, highlighting the complex sentiment surrounding regional banks.
Elon Musk forecasts China's electricity generation will outpace the United States by a factor of three within the next few years, citing the nation's breakneck expansion in solar and grid infrastructure as a pivotal shift in global energy leadership.
Despite a robust 45% surge in earnings per share, Lonza Group AG (VTX:LONN) shareholders have seen their investment decline by 11% over the past year, starkly underperforming the broader Swiss market. This divergence underscores how investor sentiment and future expectations can overshadow even solid current financial performance.
An analysis of the German beverage company's financial metrics reveals flat returns on capital and limited reinvestment, casting doubt on its potential for high growth despite a rising stock price.
CNBC's Jim Cramer expresses strong confidence in Affirm Holdings ahead of its earnings, crediting CEO Max Levchin's leadership for potentially outperforming market expectations and challenging bearish sentiment.
Institutional ownership reaches 39% at European copper producer Aurubis AG, granting major influence and exposure to the firm's performance as shares surge over 120% in a year.
After years of losses, Evolent Health has broken into profitability with a rising capital base. While its Return on Capital Employed (ROCE) remains low, the accelerating trend suggests a potential inflection point for the healthcare services firm.
Pfizer's shares have staged a notable rebound in recent months, drawing investor attention as the company pivots towards oncology. We examine whether the current valuation reflects its long-term growth potential or lingering post-pandemic challenges.
